Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease
Eur J Nucl Med Mol Imaging
.
2012 Feb;39(2):209-19.
doi: 10.1007/s00259-011-2045-0.
Authors
Victor L Villemagne
,
William E Klunk
,
Chester A Mathis
,
Christopher C Rowe
,
David J Brooks
,
Bradley T Hyman
,
Milos D Ikonomovic
,
Kenji Ishii
,
Clifford R Jack
,
William J Jagust
,
Keith A Johnson
,
Robert A Koeppe
,
Val J Lowe
,
Colin L Masters
,
Thomas J Montine
,
John C Morris
,
Agneta Nordberg
,
Ronald C Petersen
,
Eric M Reiman
,
Dennis J Selkoe
,
Reisa A Sperling
,
Koen Van Laere
,
Michael W Weiner
,
Alexander Drzezga
PMID:
22218879
PMCID:
PMC3261395
DOI:
10.1007/s00259-011-2045-0
No abstract available
Publication types
Editorial
Kommentar
MeSH terms
Alzheimer Disease / diagnosis*
Amyloid beta-Peptides / metabolism*
Humans
Positron-Emission Tomography / methods*
Radioisotopes / pharmacology*
Substances
Amyloid beta-Peptides
Radioisotopes
Grants and funding
G1100810/MRC_/Medical Research Council/United Kingdom
MC_U120036861/MRC_/Medical Research Council/United Kingdom
P30 AG019610/AG/NIA NIH HHS/United States
R01 AG006173/AG/NIA NIH HHS/United States